Navigation Links
Dr. Derek Winstanly of Quintiles to Serve as 2009 ACRO Chair; Mr. William Sharbaugh of PPD to Be Chair-Elect
Date:1/13/2009

ICON Joins as Associate Member

WASHINGTON, Jan. 13 /PRNewswire-USNewswire/ -- The Association of Clinical Research Organizations (ACRO), which represents the clinical outsourcing industry to regulators, biopharmaceutical clients, policy makers and the public in the U.S. and worldwide, today announced that it has elected Dr. Derek Winstanly as Chair for 2009 and Mr. William Sharbaugh as Chair-Elect.

Dr. Winstanly, MBChB, Executive Vice President of Strategic Business Partnerships for Quintiles Transnational, and Mr. Sharbaugh, Chief Operating Officer of PPD, were elected at the association's annual meeting in December. Dr. Winstanly is a respected leader of the clinical research organization (CRO) industry, having held various global leadership positions within Quintiles since joining the company in 1999. In his current role, as Executive Vice President, he works with senior biopharmaceutical executives to provide long-term strategic solutions, and is responsible for the Office of the Chief Medical Officer as well as the ethics and quality assurance functions of the company.

Mr. Sharbaugh joined PPD in 2007 after spending more than 16 years in the pharmaceutical industry, including senior management positions with Bristol-Myers Squibb and Merck & Co. As COO, he provides strategic direction and leadership to PPD's Phase II-IV clinical business, global central labs, information technology and human resources.

"I am delighted to lead ACRO in 2009 and to help set the organization's strategic agenda during this crucial period of development for the CRO industry," said Dr. Winstanly. "The long-term future for the CRO industry remains bright and we look forward to working with our clients, regulators and legislators globally to bring about a more efficient drug development paradigm while maintaining the highest standards of patient safety."

ACRO is also pleased to announce the
'/>"/>

SOURCE Association of Clinical Research Organizations
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Association of Clinical Research Organizations (ACRO) Names Dr. Derek Winstanly Chair-Elect
2. Honor Society of Nursing Recognizes Researcher of HIV Risk Prevention for Poor and Underserved
3. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
4. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
5. Snapshots of Eyes Could Serve as Early Warning of Diabetes or Diabetic Eye Disease, U-M Researchers Report
6. BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial
7. Photos: SOS Childrens Villages Observes World Orphan Week, October 5-11, 2008
8. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
9. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
10. Velcura Therapeutics, Inc. Adds William Brinkerhoff to its Board of Directors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...25 Heska Corporation ( H...diagnostic and specialty products to the veterinar...Diagnostics Corporation for the supply of blood ga...rinary market. ,, (Logo: http://www.newsco...ka and Roche share the same passion for innovating...
(Date:11/25/2009)...-BioTrendsResearchGroup,Inc.releasedWave1ofits La...i-phasesyndicatedmarketresearchprojecttrackingthel...aunchthroughthefirstsixmonthsofavailability.Eachwa...uniqueDermatologistsandqualitativeinformationfroma...staclestouse,typicalpatienttypes,productperception...
(Date:11/25/2009).... 25 Regado Biosciences, a private...ombotic aptamers with active control agents, annou...l be presenting at the Piper Jaffray 21st Annual H... in New York City. Dr. Mazzo,s presentation will ...d will include an overview of the Company,s pipeli...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Study to Investigate AHCC and the Swine Flu Virus 47555 1Study to Investigate AHCC and the Swine Flu Virus 47555 2Go Red For Women 28R 29 Launches 12 Week Program to Improve Heart Health and Save Lives 47553 1Go Red For Women 28R 29 Launches 12 Week Program to Improve Heart Health and Save Lives 47553 2Go Red For Women 28R 29 Launches 12 Week Program to Improve Heart Health and Save Lives 47553 3Consumer Reports 3A Hearing Aid Shoppers Pay High Prices Get Mediocre Fittings 47551 1Consumer Reports 3A Hearing Aid Shoppers Pay High Prices Get Mediocre Fittings 47551 2Consumer Reports 3A Hearing Aid Shoppers Pay High Prices Get Mediocre Fittings 47551 3Consumer Reports 3A Hearing Aid Shoppers Pay High Prices Get Mediocre Fittings 47551 4
...lly relevant model of,normal human skin found that...g the cytotoxic effect of erlotinib * Phase I sing...generally well,tolerated in metastatic melanoma pa...nventional vincristine , SOUTH SAN FRANCISCO, Cali...ces (Nasdaq:HNAB), a biopharmaceutical company foc...
... – Genta,Incorporated (Nasdaq: GNTA) announc...ical trial of its marketed product, Ganite®,(g...®;,Genentech/IDEC) and dexamethasone in patien... lymphoma (NHL). The data were,presented at the an...ncology (ASCO) in Chicago, IL. , ,Previously publi...
Other Medicine Technology:Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 2Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 3Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 4Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 5Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 2Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 3Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 4Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 5
(Date:11/27/2009)..., Nov. 27 Preventing di...d fortunately every year, new vaccines are being a...accines boost immunity for the same period of time... needed to keep immunity strong? ,, In this m...rican Academy of Pediatrics, Michael Pichichero MD...
(Date:11/27/2009)...ecedented medical, economic burdens, study predict...- The number of people with diabetes in the United...rs, a new study predicts. , That would bring th...the disease, up from 23.7 million today. , , At ...abetes will triple, the study also warns, rising f...
(Date:11/27/2009)...hree new interactive anatomy education apps from M...nd health sciences learning opportunities for iPho...m, NC (Vocus) November 27, 2009 -- Modality, Inc....ivision of Wolters Kluwer Health, today announced ...ps on the App Store. Clemente’s Anatomy, Roh...
(Date:11/26/2009)...oo heavy can lead to strains or worse , ,...be nothing wrong with stuffing your turkey full to...hing with your suitcase as you pack for holiday tr...2008 in U.S. hospital emergency rooms, doctors, of...ggage-related injuries, such as muscle strains, pu...
(Date:11/26/2009)...enton Communications announces a highly effective ...ilers struggling to make an economic recovery. , ...-- Flu fears is the type of challenge that could s...cording to Dr. David Benton, business growth exper... system – The Rfactor Intensive . “...
Breaking Medicine News(10 mins):Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Pharmacist Injects Cure for Ailing Businesses 2
...ission Includes Clinical Data Demonstrating Superi...R) Drug Eluting Stent, TOKYO, June 2 Abbott (NYS... application for Seizo Hanbai Shonin,(Marketing Au...its XIENCE(TM) V Everolimus Eluting Coronary Stent...
..., June 2 Treating pancreatic cancer with a combin... prior to surgery is safe and may be beneficial fo...h Cancer Institute (UPCI) study presented at the 4...nter of the University of Pittsburgh Medical Cente...
..., Ill., June 2 With all the concerns about,what,s...even more attention,these days to what we are givi...ng a few precautions. After all, pet,food recalls ...cording to a study in the June 1, 2008, Journal of...
..., June 2 Kensey Nash Corporation,(Nasdaq: KNSY )...sale of its,endovascular business to Spectranetics... 30, 2008. This transaction includes the sale of t...ts of the Kensey Nash and Spectranectics transitio...
...dney Care Provider Recognized by the Association o... Inspiring Tales of Patient and Teammate ...., June 2 DaVita Inc., a leading,provider of kidn...gazine: Stories from the Village, received two,pre...
...BUS, Ohio) Bunk bed-related injuries are not an i...en according to a study conducted by investigators...he Research Institute at Nationwide Childrens Hosp...unger than 10 years of age, there is a surprising ...
Other Medicine News:Health News:Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan 2Health News:Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan 3Health News:Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan 4Health News:Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan 5Health News:New treatment combination safe for pancreatic cancer patients 2Health News:Is Tap Water Safe for Your Dog? 2Health News:Kensey Nash Announces the Closing on its Sale of the Endovascular Business to Spectranetics 2Health News:Kensey Nash Announces the Closing on its Sale of the Endovascular Business to Spectranetics 3Health News:DaVita Magazine Takes Home Two Prestigious Hermes Creative Awards 2Health News:Bunk beds pose dangers to kids and adults 2Health News:Bunk beds pose dangers to kids and adults 3
Acuvue Toric
Binocular Loupes
Near Functional Acuity - Fact101
Near Point Card/Newspaper 8 to 48 - BC2203
Medicine Products: